Novartis AGNVSNYSE
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank71
5Y CAGR+18.9%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
+18.9%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20255.97%
202410.85%
20237.36%
2022-1.17%
2021-11.87%
20202.51%
20195.59%
20186.21%
2017-12.20%
2016-1.89%